ViennaLab Diagnostics GmbH of Vienna at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

ViennaLab Diagnostics GmbH

Gaudenzdorfer Guertel 43-45, 1120 Vienna
Austria
Telephone +43 1 8120156
Fax +43 1 8120156-19
info@viennalab.com

This company is co-exhibitor of
ADVANTAGE AUSTRIA Wirtschaftskammer Österreich

Hall map

MEDICA 2018 hall map (Hall 3): stand F56

Fairground map

MEDICA 2018 fairground map: Hall 3

Contact

PhD Birgit Luef

International Marketing

Vienna, Austria

Phone
0043-1-8120156-12

Email
marketing@viennalab.com

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer

Diagnostic tests for cancer

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

DNA testing

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.02  Molecular biomarkers

Molecular biomarkers

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Polymerase chain reaction (PCR)

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Other molecular diagnostics testing

About us

Company details

ViennaLab Diagnostics, an Austrian company, has been successful in developing, manufacturing and worldwide distributing genetic tests since its foundation in 1990.

ViennaLab StripAssays® and RealFast™ Assays are easy, reliable and affordable human in vitro diagnostic tests covering the following fields: Inherited Diseases, Genetic Predispositions, Pharmacogenetics and Oncology.

Assays are offered for Cardio-Vascular Diseases, Thalassemias, Cystic Fibrosis, Familial Mediterranean Fever, Alzheimer Disease, Sugar Intolerance, among others. Products of the pharmacogenetics and oncology portfolio help to achieve safer and more individualized anticoagulant and cancer therapies.

Based on polymerase chain reaction (PCR) and reverse hybridization, the well-established and user-friendly StripAssays® accomplish up to 48 immobilized probes for wild-type and mutated alleles. StripAssays® require standard laboratory equipment, making them very easy to implement. For high-volume users, automation of the entire teststrip processing is available. StripAssay® results can be either read by eye or interpreted with a proprietary scanner-based software (Evaluator).

RealFast™ Assays are based on TaqMan® real-time PCR technology and allow the rapid and reliable detection of single nucleotide polymorphisms (SNPs) as well as copy number variations (CNVs).

All ViennaLab products are CE/IVD marked and manufactured according to the quality standards of ISO 9001 and ISO 13485. StripAssays® and RealFast™ Assays also regularly participate in international research studies and in external quality assessment (EQA) schemes, which allow scientific evidence of the quality employed.

To find out more, please visit www.viennalab.com.

More Less

Company data

Number of employees

20-49

Foundation

1990

Area of business

Diagnostics

Company information as a PDF file